Literature DB >> 11073541

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.

K A Metcalfe1, A Liede, E Hoodfar, A Scott, W D Foulkes, S A Narod.   

Abstract

BACKGROUND: The discovery of the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 has improved our ability to counsel women at increased risk of developing breast and ovarian cancer. The objective of our study was to identify the needs of women who have undergone genetic counselling and testing for BRCA1/2 and to determine the impact of receiving a positive BRCA1/2 result. This is the first study to report on a large group of women who have received positive BRCA1/2 mutation results.
METHODS: Questionnaires were distributed to 105 women who had received pre- and post-test genetic counselling for a positive BRCA1/2 result at the University of Toronto or at McGill University in Montreal, Canada between the years of 1994 and 1998. The questionnaire items included patient motivation for seeking genetic services, information needs, screening and prophylactic surgery practices, satisfaction with access to services and support, the desire for a support group, and overall client satisfaction.
RESULTS: Seventy nine female carriers were surveyed. The majority of the respondents (77%) were satisfied with the information they received during the genetic counselling process. Women with a previous diagnosis of cancer indicated that they needed more information relating to cancer treatment compared to women without cancer (p=0.05). Nineteen percent of the women felt they needed more support than was received. Fifty eight percent of the women reported that their screening practices had changed since they received their result. Young women (below the age of 50) and women with no previous diagnosis of cancer were most likely to have changed their screening practices. Nearly two thirds of the respondents said they had considered prophylactic surgery of the breasts or ovaries. Twenty eight percent of the women had prophylactic mastectomy and 54% had undergone prophylactic oophorectomy. Women with an educational level of high school or more were more likely to have undergone prophylactic bilateral mastectomy than those with less education (p=0.07) but were less likely to undergo prophylactic oophorectomy (p=0.0007).
CONCLUSION: These findings have a direct impact on the counselling and risk management of female BRCA mutation carriers. Age, education, and a previous diagnosis of cancer are important determinants in a woman's decision making after receiving positive genetic test results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073541      PMCID: PMC1734476          DOI: 10.1136/jmg.37.11.866

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

Review 1.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Authors:  K F Hoskins; J E Stopfer; K A Calzone; S D Merajver; T R Rebbeck; J E Garber; B L Weber
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

4.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Authors:  C Lerman; S Narod; K Schulman; C Hughes; A Gomez-Caminero; G Bonney; K Gold; B Trock; D Main; J Lynch; C Fulmore; C Snyder; S J Lemon; T Conway; P Tonin; G Lenoir; H Lynch
Journal:  JAMA       Date:  1996-06-26       Impact factor: 56.272

5.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

6.  Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Authors:  C Lerman; M Daly; A Masny; A Balshem
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

7.  Informational needs of individuals and families with hereditary cancers.

Authors:  P T Kelly
Journal:  Semin Oncol Nurs       Date:  1992-11       Impact factor: 2.315

8.  Interest in genetic testing among first-degree relatives of breast cancer patients.

Authors:  C Lerman; J Seay; A Balshem; J Audrain
Journal:  Am J Med Genet       Date:  1995-07-03

9.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

10.  Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.

Authors:  T M Wagner; R Möslinger; G Langbauer; R Ahner; E Fleischmann; A Auterith; A Friedmann; T Helbich; C Zielinski; E Pittermann; M Seifert; P Oefner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  28 in total

1.  Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.

Authors:  Vardit Kram; Tamar Peretz; Michal Sagi
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  "Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation.

Authors:  Regina Kenen; Audrey Ardern-Jones; Rosalind Eeles
Journal:  J Genet Couns       Date:  2006-06       Impact factor: 2.537

Review 3.  Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Authors:  Gillian Nycum; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

4.  Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.

Authors:  Carin R Espenschied; Deborah J MacDonald; Julie O Culver; Sharon Sand; Karen Hurley; Kimberly C Banks; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

5.  Concerns of South Korean patients and family members affected with genetic conditions: a content analysis of internet website messages.

Authors:  Heejung Kang; Patricia McCarthy Veach; Bonnie S Leroy
Journal:  J Genet Couns       Date:  2010-01-20       Impact factor: 2.537

6.  Cancer risk assessment by rural and Appalachian family medicine physicians.

Authors:  Kimberly M Kelly; Margaret M Love; Kevin A Pearce; Kyle Porter; Mary A Barron; Michael Andrykowski
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

7.  Determinants of preferences for genetic counselling in Jewish women.

Authors:  Carmel Apicella; Stuart J Peacock; Lesley Andrews; Katherine Tucker; Agnes Bankier; Mary B Daly; John L Hopper
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

8.  Implementing a telephone based peer support intervention for women with a BRCA1/2 mutation.

Authors:  Ashley Farrelly; Victoria White; Mary-Anne Young; Michael Jefford; Sandra Ieropoli; Jessica Duffy; Ingrid Winship; Bettina Meiser
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

9.  Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.

Authors:  Michelle Proulx; Marie-Dominique Beaulieu; Christine Loignon; Marie-Hélène Mayrand; Christine Maugard; Nathalie Bellavance; Diane Provencher
Journal:  J Genet Couns       Date:  2009-02-14       Impact factor: 2.537

10.  Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.

Authors:  Kelly A Metcalfe; Parviz Ghadirian; Barry Rosen; William Foulkes; Charmaine Kim-Sing; Andrea Eisen; Peter Ainsworth; Doug Horsman; Christine Maugard; Diane Provencher; André Robideaux; Dawna Gilchrist; Albert Chudley; Edmond G Lemire; Susan Armel; Amy Finch; Ping Sun; Steven A Narod
Journal:  Open Med       Date:  2007-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.